A new Journal of Neurology case report describes recurrent posterior stroke-like brain lesions that were ultimately revealed ...

A study investigated the origin of ataxia in the brain of patients with stroke. A significant number of the stroke lesions in the patients were located outside the cerebellum. A new study by the ...

A clear timeline for when a new drug for Friedreich’s ataxia will reach patients is urgently needed with one Cork father fearing it could take many months. It emerged this week the HSE expects to have ...

PLANO, Texas--(BUSINESS WIRE)-- Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” “our,” “us,” or “we”), a biopharmaceutical ...

A year-long Dutch study shows the PROM-Ataxia questionnaire validly captures disease burden in spinocerebellar ataxia, even ...

Patients with Friedreich's Ataxia have called for change following their successful campaign for the HSE to fund the drug Skyclarys, saying that other rare disease patients should not have to "beg" ...

Please provide your email address to receive an email when new articles are posted on . Approximately 5,000 people in the United States have Friedreich’s ataxia. Advocates virtually met with ...

Difficulty balancing or an inability to do so can be caused by any number of factors. Head injuries, migraines, alcohol use, ear infections and medications can all affect your musculoskeletal system ...

LAS VEGAS, June 5, 2025 /PRNewswire/ -- DelveInsight's Friedreich's Ataxia Market Insights report includes a comprehensive understanding of current treatment practices, Friedreich's ataxia emerging ...

Please provide your email address to receive an email when new articles are posted on . Reata Pharmaceuticals announced that Skyclarys is now commercially available for patients older than 16 years ...

Atop exercise researcher at the University of Virginia School of Medicine is urging clinical trials of exercise in patients with Friedreich's ataxia after finding that physical activity has a ...